VINCERX PHARMA INC (VINC)

US92731L1061 - Common Stock

0.6906  -0.03 (-4.08%)

Premarket: 0.6906 0 (0%)

Fundamental Rating

2

VINC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 586 industry peers in the Biotechnology industry. The financial health of VINC is average, but there are quite some concerns on its profitability. VINC has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

VINC had negative earnings in the past year.
In the past year VINC has reported a negative cash flow from operations.
In the past 5 years VINC always reported negative net income.
VINC had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -220.43%, VINC is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -357.82%, VINC is doing worse than 75.99% of the companies in the same industry.
Industry RankSector Rank
ROA -220.43%
ROE -357.82%
ROIC N/A
ROA(3y)-121.36%
ROA(5y)N/A
ROE(3y)-178.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VINC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

The number of shares outstanding for VINC has been increased compared to 1 year ago.
There is no outstanding debt for VINC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

VINC has an Altman-Z score of -17.60. This is a bad value and indicates that VINC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -17.60, VINC is doing worse than 86.28% of the companies in the same industry.
There is no outstanding debt for VINC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -17.6
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

VINC has a Current Ratio of 2.63. This indicates that VINC is financially healthy and has no problem in meeting its short term obligations.
VINC has a Current ratio of 2.63. This is in the lower half of the industry: VINC underperforms 70.84% of its industry peers.
VINC has a Quick Ratio of 2.63. This indicates that VINC is financially healthy and has no problem in meeting its short term obligations.
VINC's Quick ratio of 2.63 is on the low side compared to the rest of the industry. VINC is outperformed by 69.13% of its industry peers.
Industry RankSector Rank
Current Ratio 2.63
Quick Ratio 2.63

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.42% over the past year.
EPS 1Y (TTM)39.42%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q64.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 9.86% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y44.68%
EPS Next 2Y22.18%
EPS Next 3Y13.03%
EPS Next 5Y9.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

VINC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VINC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

VINC's earnings are expected to grow with 13.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.18%
EPS Next 3Y13.03%

0

5. Dividend

5.1 Amount

No dividends for VINC!.
Industry RankSector Rank
Dividend Yield N/A

VINCERX PHARMA INC

NASDAQ:VINC (5/17/2024, 7:00:02 PM)

Premarket: 0.6906 0 (0%)

0.6906

-0.03 (-4.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap20.39M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -220.43%
ROE -357.82%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.63
Quick Ratio 2.63
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)39.42%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y44.68%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y